PUBLISHER: Inkwood Research | PRODUCT CODE: 1047090
PUBLISHER: Inkwood Research | PRODUCT CODE: 1047090
The India clinical trial management market is estimated to project a CAGR of 15.07% during the forecast period, 2022-2028. The increasing disease burden, reduced approval period, high population, and online registry contribute to market growth.
The digitalization of clinical trials is expected to drive market growth in India. It has facilitated the streamlining of many clinical trial processes like logistics and supplies management, regulatory compliance, data capture, etc. The launch of digital therapeutics and the ease of real-time data acquisition related to safety & toxicity enables timely rectification in trial design, thereby promoting the market growth.
Furthermore, a significant percentage of the Indian population does not have access to advanced treatment and medicines, given the financial and geographic barriers. As per the Institute for Studies in Industrial Development Report, the country ranks second with regard to patient population for clinical trials. Also, the clinical trials are half-priced from that of Europe and the US. Moreover, the country is also emerging as a top destination for contract research organizations, given its acceptance of international intellectual property rights and guidelines, accessible human resources, low operational costs, availability of a large patient pool, and diverse climatic conditions. Such factors are predicted to influence the growth of the India clinical trial management market.
Some of the prominent companies in the market are: Parexel International Corporation, Oracle Corporation, ArisIndia LLC, Veeva Systems Inc, Medidata Solutions Inc, etc.